Prussian Blue Nanozyme with Multienzyme Activity Reduces Colitis in Mice-Reference-Cited by-同舟云学术

Prussian Blue Nanozyme with Multienzyme Activity Reduces Colitis in Mice

Published:2018-07-20 Issue:31 Volume:10 Page:26108-26117
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhao Jiulong¹,Cai Xiaojun²³,Gao Wei³,Zhang Linlin²,Zou Duowu¹^ORCID,Zheng Yuanyi³^ORCID,Li Zhaoshen¹,Chen Hangrong²^ORCID

Affiliation:

1. Department of Gastroenterology, Changhai Hospital, Second Military Medical University, 200433 Shanghai, P. R. China

2. State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, 200050 Shanghai, P. R. China

3. Shanghai Institute of Ultrasound in Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 200050 Shanghai, P. R. China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.8b10345

Reference28 articles.

1. Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

2. Inflammation and colorectal cancer: colitis-associated neoplasia

3. Inflammatory Bowel Disease

4. Unravelling the pathogenesis of inflammatory bowel disease

5. Intestinal homeostasis and its breakdown in inflammatory bowel disease

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal organic framework modulated nanozymes tailored with their biomedical approaches;CHINESE CHEM LETT;2024

2. Recent advances in MOF-based nanozymes: Synthesis, activities, and bioapplications;Biosensors and Bioelectronics;2024-11

3. Biomedical potential of nanozymes: Harnessing redox enzyme mimicry for theranostic applications;Coordination Chemistry Reviews;2024-10

4. Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease;Journal of Controlled Release;2024-09

5. Stimulus-Responsive Drug Delivery Nanoplatforms for Inflammatory Bowel Disease Therapy;Acta Biomaterialia;2024-09